Innovation Pharmaceuticals Submits Material Transfer Agreement to Study Lead Defensin Mimetic Brilacidin for Coronavirus  (COVID-19)

NEXT STORY
10x Genomics Debuts Range of New Products at AGBT
PREV STORY
Generex Congratulates their Shareholders as FINRA has Officially Posted the Approval of the Generex Corporate Action and Payment of the Generex and NuGenerex Immuno-Oncology Stock Dividends on Monday, February 24, 2020
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aquafeed Market Size, Share and Outlook by 2028 | Aquafeed Industry Research, Benefits, Opportunities and Forecast Report by Fortune Business Insights™

author_avatar
NASDAQ Market News

VBL Therapeutics Announces Publication of Positive New Data on its Lecinoxoid Drug Candidates for the Treatment of Renal Fibrosis

These data, together with positive preclinical NASH data previously presented, support the potential of ...

author_avatar
NASDAQ Market News

Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential Cure for Hepatitis B Virus Infection

author_avatar
NASDAQ Market News